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Objectives: Inflammation is an underlying mechanism behind fibrotic processes and
differentiation of cells into myofibroblasts. Presented study therefore provides new data
on activation of autoimmune and inflammatory immune response genes that accompany
activation of p38 and cell differentiation in primary cells derived from Dupuytren’s disease
(DD) patients.
Methods: Primary non-Dupuytren’s disease cells (ND) were isolated from
macroscopically unaffected palmar fascia adjacent to diseased tissue obtained
from patients diagnosed with the last stage of DD and cultured in vitro. Gene expression,
collagen gel contraction assay and analysis of secreted proteins were performed in ND
cells treated with TGF-β1 and/or inhibitor of p38 phosphorylation.
Results: During differentiation of ND fibroblasts, increased expression of immune
response genes PAI-1, TIMP-1, CCL11, and IL-6 was found. These changes were
accompanied by increased cell contractility and activation of p38 and its target kinase
MK2. Inhibition of p38 phosphorylation reversed these processes in vitro.
Conclusions: TGF-β1 induced p38 phosphorylation in ND cells grown from
macroscopically unaffected palmar fascia adjacent to diseased tissue from DD patients.
This was accompanied by activation of the cytokine genes CCL-11 and IL-6 and
secretion of extracellular matrix regulatory proteins PAI-1 and TIMP-1. A combined
approach directed toward inflammation and p38MAPK-mediated processes in DDmight
be considered for improving management of DD patients and prevention of recurrence.
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INTRODUCTION
Fibrotic and fibroproliferative disorders may affect all tissues causing loss of tissue structure
and function (Wynn, 2008). This process involves differentiation of cells into myofibroblasts
accompanied by extracellular matrix deposition. Benign and malignant fibroproliferative disorders
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include idiopathic pulmonary fibrosis, hepatic cirrhosis,
myelofibrosis, systemic sclerosis, Dupuytren’s disease
(DD), hypertrophic scars, and keloids (Huang and Ogawa,
2012). Common mechanisms occur in these fibrotic
processes that include persistent inflammation and local
overproduction/activation of different cytokines (Ghosh and
Vaughan, 2012; Huang and Ogawa, 2012). For example,
infiltrating immune cells in DD excrete large amount of different
cytokines, chemokines and growth factors, especially TGF-β1
(Baird et al., 1993), cytokine that induces typical phenotypic
changes and inflammation (Parsonage et al., 2005; Lupher
and Gallatin, 2006). Under such conditions, cells may acquire
myofibroblast phenotype. Myofibroblasts are active components
of innate immune system and may regulate switches from
acute to chronic inflammation (Kalluri and Zeisberg, 2006). In
particular, activated myofibroblasts express MHC I and MHC II
antigens (Brennan et al., 1990; Knittel et al., 1999) and respond
to pro-inflammatory cytokines TNF-α and IFN-γ by releasing
chemokine CCL2 (Marra et al., 1993), inflammatory mediators
IL-1, IL-6, IL-8, prostaglandins and hyaluronate (Yellin et al.,
1995; Sempowski et al., 1997; Schwabe et al., 2001). Moreover,
during wound healing, phagocyte apoptotic cells and activate
TGF-β1, a central mediator of fibrosis (Canbay et al., 2003).
Molecular mechanisms underlying fibroproliferative disorders
have been studied for years by different approaches including
modern large-scale methodologies but effective treatments for
this group of disease are still missing. For example, surgery
is still the only available option for DD patients even though
high recurrence rates are usually observed. Novel potential
therapeutic targets for DD and fibroses have therefore, been
studied, including reactive oxygen species-dependant TGF-β
signaling (Samarakoon et al., 2013), focal adhesion kinases
(Lagares and Kapoor, 2013), and inflammatory cytokine TNF
(Verjee et al., 2013). In the present paper, we analyzed the
expression of pro-inflammatory cytokine genes in primary
cells grown from DD patients and found that TGF-β1 induced
p38 phosphorylation in ND cells grown from macroscopically
unaffected palmar fascia adjacent to diseased tissue from
DD patients is accompanied by activation of the cytokine
genes CCL-11 and IL-6 and secretion of extracellular matrix
regulatory proteins PAI-1 and TIMP-1, which casts new light on
pathogenesis of DD.
MATERIALS AND METHODS
Primary Cell Cultures
Clinical specimens were collected in strict compliance with
the clinic’s chief pathologist and the ethics committee for
research involving human subject at Clinical Hospital “University
Hospital Centre Rijeka” in Croatia. Informed consent was signed
by all patients. The cells were isolated according to established
protocols (Tse et al., 2004; Pavelic et al., 2009). Primary ND cells
were obtained from macroscopically unaffected palmar fascia
adjacent to the disease tissue. Tissue samples were collected
from six patients (age range 54–75 years, males) diagnosed
with the last stage of DD. Second passages were used for all
experiments to assure uniformity and prevent loss of original
cell phenotype. ND cells were cultured as monolayers and
maintained in Dulbecco’s modified Eagle medium (DMEM,
Gibco, Invitrogen, USA) supplemented with 10% fetal bovine
serum (FBS, Gibco, Invitrogen, USA), 2mML-glutamine (Gibco,
Invitrogen, USA), 100 U/mL penicillin (Gibco, Invitrogen, USA),
and 100µg/mL streptomycin (Gibco, Invitrogen, USA) in a
humidified atmosphere with 5% CO2 at 37◦C until they reached
80% confluence.
Western Blotting
ND cells were treated with TGF-β1 or SB203580 inhibitor and
TGF-β1 for 16 h. Cells were lysed in the buffer containing
50mM Tris HCl (pH 8), 150mM NaCl, 1% NP-40, 0.5%
sodium deoxycolate, 0.1% SDS, protease inhibitor cocktail
(Roche, Basel, Switzerland) and phosphatase inhibitor cocktail
(Thermo Scientific, Waltham, Massachusetts, USA). Protein
concentration was determined with DC Protein Assay Kit
(BIO-RAD, USA) and a total of 40µg of proteins were
resolved on 9% polyacrylamide gels using the Mini-protean
cell (Bio-Rad, Foster City, CA, USA), and analysis was
performed by previously established procedure (Pavelic et al.,
2009). The membranes were incubated with primary antibodies
raised against phosphorylated MAPKAPK-2 (MK2; 1:1000,
phospho-MAPKAPK-2, Cell Signaling technology, Danvers,
Massachusetts, USA) at 4◦C overnight. Secondary antibody
linked to anti-rabbit (1:1300, Dako, Denmark) horseradish
peroxidase was used. The signal was visualized by Western
Lightening Chemiluminescence Reagent Plus Kit (Perkin Elmer,
Waltham,Massachusetts, USA) on the VersaDoc Imaging System
4000 (Bio-Rad, Foster City, CA, USA). α-tubulin was used as
a loading control (1:1000, Sigma-Aldrich, St. Louis, Missouri,
USA).
Expression Analysis of Cytokines and
Cytokine Receptors by PCR Array
For detection of gene expression involved in cytokine
inflammatory and autoimmune response pathway-focused
RT2 Profiler PCR Array: Human Inflammatory Response and
Autoimmunity (PAHS-077A, SABiosciences, Valencia, CA, USA)
was used. Analysis was conducted according to manufacturer
recommendations. confluent ND cells (80%) were deprived of
serum for 2 h prior to treatment with TGF-β1 (3 ng/mL in serum
free medium, R&D Systems, McKinley Place, MN, USA) and
TGF-β1 together with the inhibitor of p38 phosphorylation
SB203580 (10µM, Calbiochem, Darmstadt, Germany). In dual
treatment, cells were first incubated with inhibitor SB203580 for
30min and then stimulated with TGF-β1. After 16 h total RNA
was isolated using RNAeasy spin columns (Qiagen, Valencia, CA,
USA). First strand cDNA synthesis reaction mix containing RT
cocktail was incubated with genomic DNA elimination mixture
at 42◦C for 15min and afterwards immediately heated at 95◦C
for 5min. To each of cDNA synthesis reactions, the RNase-free
water was added up to 102µl and the samples were stored
overnight at −20◦C. A total of 25µl of prepared experimental
cocktail was added to each well of PCR array. Thermal cycling
conditions consisted of initial denaturation step, 1 cycle of
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95◦C for 10min, 40 cycles of 95◦C for 15 s and annealing and
extension at 60◦C for 1min. For data analysis, free PCR array
data analysis web portal was used (http://www.SABiosciences.
com/pcrarraydataanalysis.php).
Protein Fractionation by Sodium Dodecyl
Sulfate Polyacrylamide Gel Electrophoresis
(SDS-PAGE)
After 16 h, conditioned media (20ml) where ND cells treated in
the same manner as cell used for expression analysis were grown,
was collected on ice, centrifuged at 4◦C by 1500 rpm for 15min
to remove cells and debris and supplemented with complete
protease inhibitor cocktail (Roche, Basel, Schwitzerland).
The samples were concentrated by ultra-filtration (Millipore,
Billerica, MA, USA, Centricon, 3 kDa cut-off) at 4◦C by
12,000 rpm. Concentrated samples were dissolved in a buffer
containing 7M urea, 2M thiourea, 4% CHAPS, 0.2% Bio-Lyte
ampholyte pH 3–10 (Bio-Rad), 1% DTT and 1X protease
inhibitor cocktail (Roche, Basel, Schwitzerland). The protein
concentration was determined by Bradford Assay (Bio-Rad,
Foster City, CA, USA) as described previously (Pavelic et al.,
2009).
One-Dimensional Polyacrylamide Gel
Electrophoresis
One-dimensional polyacrylamide gel electrophoresis (SDS-
PAGE) was performed on a Bio-Radmini-Protean system. A total
of 40µg of proteins were resolved on the 12% one-dimensional
polyacrylamide gel. Gels were stained with Coomassie Brilliant
Blue G-250 (Bio-Rad, Foster City, CA, USA) and scanned by
VersaDoc Imaging System 4000 (Bio-Rad, Foster City, CA, USA).
Qualitative image analysis was carried out using PDQuest SW,
7.0 (Bio-Rad, Foster City, CA, USA).
Trypsin Digestion and Mass Spectrometry
The lanes were manually excised into 24 bands (eight bands
per lane) which were processed for tryptic digestion according
to standard protocol (Shevchenko et al., 2006). Briefly, after
destaining step with 40% methanol/10% acetic acid, gel plugs
were incubated with 50mM ammonium bicarbonate for 10min
at 37◦C and then subsequently incubated with 50% ammonium
bicarbonate/50% acetonitrile (ACN) at 37◦C. After incubation
with 50% acetonitrile for 5min at 37◦C the proteins were
digested with 10 ng/µl of trypsin in ammonium bicarbonate
overnight at 37◦C. Upon completion and digestion, 0.1%
TFA was added per well. Each tryptic peptide mixture thus
generated was concentrated, desalted with C18 ZipTip (Millipore,
Billerica, MA, USA), and subsequently eluted with 4mg of
cyano-4-hydroxycinnamic acid in 60% acetonitrile and 0.1%
trifluoroacetic acid onto MALDI sample plate. The samples
were analyzed on the 4800 Plus MALDI TOF/TOF analyzer
(Applied Biosystems Inc., Foster City, CA, USA) equipped
with Nd:YAG laser operating at 200Hz. All mass spectra were
recorded from 750 to 4000 Da in positive reflectron mode.
MS spectra were recorded for all sample spots on the plate
and internally calibrated using signals from auto-proteolytic
fragments of trypsin. Up to three spectral peaks per spot that met
threshold criterion were included in the acquisition list for the
MS/MS spectra analysis. Peptide fragmentation was performed at
collision energy of 1 kV and collision gas pressure of ∼2 × 10−7
Torr.MS andMS/MS spectra generated were searched against the
Swiss-Prot and NCBI databases, respectively, using the Mascot
software (Matrix Science, Boston, MA, USA). Monoisotopic
peptide masses were used for combinedMS andMS/MS database
search in order to obtain protein identities. Following search
criteria were applied: maximum allowed peptide mass error
20 ppm; fragment mass tolerance, ±0.3 Da; minimum 5 S/N;
and a maximum of one incomplete cleavage per peptide. Only
significant hits defined by the Mascot scoring and probability
analysis (P = 0.05) were accepted as significant results.
qRT-PCR
We tested expression of PAI-1 and TIMP-1 genes using SYBR
Green-based qPCR. Total RNA was isolated from ND cells
according previously described experiment for RT2 Profiler
PCR Array and was reversely transcribed into cDNA by High
Capacity cDNA Reverse Transcription Kit (Applied Biosystems)
on GenAmp PCR System 2400 (Applied Biosystems). Primer
pairs were designed by the software “Real Time PCR Tool” from
Integrated DNA Technologies (http://eu.idtdna.com/scitools/
Applications/RealTimePCR/). Designed primers were tested
for specificity to give only one band (confirmed by gel
electrophoresis and melting curve analysis) and conditions of
reactions were optimized so that efficiency of PCR reaction was
95–100% (Table 1). Relative quantification values were obtained
from the threshold cycle number of analyzed genes measured in
triplicate and normalized with onemost stable control gene using
geNorm program. As control gene s18 rRNA was employed.
Results were processed with REST 2008V2.0.7.
After initial denaturation at 95◦C for 3min, 40 cycles of
PCR were performed in AB 7300 Real-Time PCR System
(Applied Biosystems, Foster City, CA, USA). Each cycle included
denaturation at 95◦C for 1min, annealing at 60◦C (see Table 1)
for 30 s, and extension at 72◦C for 10 s, followed by melting curve
program.
Collagen Gel Contraction Assay
Collagen gels were prepared as described by Ngo et al.
(2006). Briefly, fibroblasts were re-suspended in 400µl DMEM
supplemented with 0.2% FCS and added to 200µl collagen
TABLE 1 | Primers used for the qRT-PCR analysis.
Gene Sequence 5′–3′ Size Conditions
18SrRNA For GTAACCCGTTGAACCCCATT 151bp 60◦C, 3.5mM
MgCl2Rev CCATCCAATCGGTAGTAGCG
PAI-1 For TGGAACAAGGATGAGATCAG 262bp 60◦C, 3mM
MgCl2Rev CCGTTGAAGTAGAGGGCATT
TIMP-1 For AGGCTCTGAAAAGGGCTTCCA 150bp 60◦C, 3mM
MgCl2Rev GAGTGGGAACAGGGTGGACA
Frontiers in Molecular Biosciences | www.frontiersin.org 3 December 2015 | Volume 2 | Article 68
Bujak et al. Inflammatory Genes in Dupuytren’s Disease
suspension (3mg/ml) yielding the final concentration of 150 000
cells/ml and 1mg/ml collagen. Cell suspension containing 500µl
collagen was cast into each well of 24-well tissue culture plate and
incubated at 37◦C for 1 h in order to facilitate polymerization.
After gelation, the gels were released from the surface of
the culture well using a sterile tip. Gels were pre-incubated
with synthetic p38 phosphorylation inhibitor SB203580 for
1 h. After stimulation with TGF-β1 (3 ng/mL) for 24, 48, and
72 h in the presence or absence of SB203580, contraction was
digitally photo-documented at 24, 48, and 72 h. Contraction
quantification was performed using NIH image software (http://
rsb.info.nih.gov/nih-image/).
RESULTS
Inflammatory and Autoimmune Gene
Expression in Differentiating Primary DD
Cells is Linked with the Activation of p38
MAPK Signaling
We previously reported on the involvement of p38 MAPK
signaling pathway in primary cells grown from DD patients
(Ratkaj et al., 2012). In the present paper, we studied p38
MAPK downstream target, specifically MK2 kinase, during
differentiation of primary ND cells into myofibroblasts. This
kinase is exclusively phosphorylated by activated p38 and
was previously implicated in myofibroblast differentiation and
fibrotic processes other than DD (Liu et al., 2007). We
detected stable endogenous expression of phosphorylated MK2
form in cells grown from macroscopically unaffected palmar
fascia adjacent to diseased tissue (ND cells) prior and upon
treatment with TGF-β1 (Figure 1A). However, in cells co-
incubated with TGF-β1 and p38 phosphorylation inhibitor, the
levels of phosphorylated MK2 diminished. Interestingly, active
form of MK2 was detected in untreated ND fibroblasts as well,
which could be attributed to the well-known role of p38 MAPK
signaling in homeostasis of palmar fascia fibroblasts or in the
intrinsic predisposition of normal palmar fibroblasts in DD
patients for disease development. Since MK2 is involved in the
regulation of inflammatory response within p38-MAPK signaling
pathway (Gaestel, 2013), we analyzed changes in the expression
profile of genes involved in inflammation and autoimmune
response during the differentiation process. Obtained results
showed that activation of p38 MAPK signaling by TGF-β1 in
ND cells directly influences expression of a number of tested
genes (Figure 1B) including genes encoding for chemokine (C-
C motif) ligand 11 (CCL11), interleukin 6 (IL-6), chemokine
(C-C motif) ligand 2 (CCL2), and interleukin 1 receptor
accessory protein (IL1RAP) that were found to be over-expressed.
Inhibition of p38 phosphorylation partially reversed this process
and significantly down-regulated genes CCL11 and IL1RAP.
Similar down-regulation was also observed for IL-6. A number
FIGURE 1 | Phosphorylation status of MAPKAPK-2 kinase and expression of cytokine and cytokine receptors in ND cells treated with TGF-β1 or
TGF-β1 and inhibitor of p38 phosphorylation. Panel (A) representative western blots showing phosphorylated MAPKAPK-2 in untreated ND cells (1), ND cells
treated with TGF-β1 (2) and ND cells incubated with TGF-β1 and p38 phosphorylation inhibitor SB203580 (3), expression of α-tubulin in ND cells was used as loading
control; Panel (B) changes in gene expression observed in ND fibroblasts treated with TGF-β1 (black columns) or treated with TGF-β1 and p38 phosphorylation
inhibitor SB203580 (gray columns). The results are presented as gene expression fold change between treated cells and control. *Statistically relevant changes
(p < 0.05) in comparison to control.
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of genes had lower expression levels in ND cells activated by
TGF- β1 including those coding for complement component
(C3), fms-related tyrosine kinase 3 ligand (FLT3LG), interleukin
6 receptor (IL6R), lymphocyte antigen 96 (LY96), toll-interleukin
1 receptor (TIR) domain containing adaptor protein (TIRAP),
toll-like receptor (TLR3), toll like receptor 5 (TLR5), and
histone deacetylase 4 (HDAC4). Majority of the genes whose
expression levels were altered by TGF-β1 showed reversed
expression pattern upon treatment with the inhibitor of p38
phosphorylation. Obtained results thus support previous studies
reporting on p38 MAPK pathway involvement in inflammation
processes during fibroblast differentiation. Since myofibroblast-
like phenotype includes initiation of extensive extracellular
matrix deposition driven by inflammatory factors such as for
example TGF-β1 and TNF-α (Reeves and Friedman, 2002), we
profiled secretome of ND cells.
Analysis of Proteins Secreted by ND Cells
We analyzed all secreted proteins (the secretome) from untreated
(control), TGF-β1-activated ND cells and ND cells treated with
TGF-β1 and inhibitor of p38 phosphorylation (Figure 2).
Differentially expressed proteins are presented in Table 2.
Extracellular matrix proteins were expectedly identified as
a major group of secreted proteins. Incubation with TGF-
β1 alone or in combination with the p38 phosphorylation
inhibitor induced expression of matrix metalloproteinase-2
(MMP-2), collagen alpha-5(VI) chain (COL4A5), plasminogen
activator inhibitor 1 (PAI-1), and tissue inhibitor of matrix
metalloproteinases 1 (TIMP-1), in comparison with control
cells (Table 2). TIMPs and indirectly PAI-1 are key inhibitors
of MMPs and other enzymes that degrade ECM proteins. Their
expression was validated at the gene level as well (Figure 3).
Addition of p38 phosphorylation inhibitor significantly
decreased changes induced by TGF-β1 treatment (diminished
expression of TIMPs and PAI-1genes). Ulrich et al. (2009)
showed that TIMP-1 is the only TIMP whose expression is
increased significantly in the DD nodule in comparison with
normal palmar fascia. Surprisingly, until now there was no
evidence on PAI-1 gene expression in fibroblasts activated by
TGF-β1 from palmar fascia.
Collagen Gel Contraction Assay
Our previous results (Pavelic et al., 2009; Ratkaj et al.,
2012) showed a connection between p38 MAPK activation
and differentiation of fibroblasts into myofibroblasts and
acquirement of their contractive phenotype. In the absence of
an animal model to study the effect of p38 phosphorylation
inhibition in DD cells during differentiation process, we used
three-dimensional collagen lattice where the cells were grown
on the mouse collagen type I layer. Type I collagen is
abundantly present in healthy palmar fascia and therefore
suitable to study fibroblast contraction during differentiation into
myofibroblasts. Obtained results are presented in Figures 4A,B.
FIGURE 2 | Representative SDS-PAGE gels (12% bis-Tris gel) with
proteins secreted into the cell growth medium by ND cells treated with
TGF-β1 or with a combination of TGF-β1 and p38 phosphorylation
inhibitor SB203580 under serum-free conditions. Numbers denote bands
with proteins which were excised, digested, and analyzed by mass
spectrometry.
TABLE 2 | Proteins expressed in the cell growth medium of ND cells.
Position on
the gel
Protein name Accession number/ncbi MW Treatment Protein score (CI %)
1,2,3 Fibronectin 1/FN1 gi|119590953 137,642 Control, TGFβ, TGFβ+ SB 100
5 Pro alpha 1(I) collagen COL1A2 gi|186893270 138826.6 TGFβ 100
8,9 Collagen, type II, alpha 1/COL2A1 gi|119578373 131077.4 TGFβ, TGFβ+ SB 100
11,12 Matrix metalloproteinase-2/MMP-2 gi|5822007 70872.2 TGFβ, TGFβ+ SB 100
14,15 Collagen alpha-5(VI) chain COL4A5 gi|183583553 279755.7 TGFβ, TGFβ+ SB 100
16,17 Matrix metalloproteinase 1/MMP1 gi|54697154 53947.7 Control, TGFβ 100
20,21 Plasminogen activator inhibitor −1/PAI-1 gi|755747 143389.2 TGFβ, TGFβ+ SB 100
23 Tissue inhibitor of matrix metalloproteinases
1/TIMP-1
gi|57210052 12526.5 TGFβ 100
(1) Control ND cells (untreated cells), (2) ND cells treated with TGF-β1 (3 ng/ml), and (3) ND cells treated with TGF-β1 (3 ng/mL) and p38 phosphorylation inhibitor SB203580 (10µM).
Proteins were resolved on SDS-PAGE, cut from the gel, digested, and identified by mass spectrometry.
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FIGURE 3 | Changes of PAI-1 and TIMP-1 gene expression in ND cells treated with TGF-β1 (black columns) or with TGF-β1 and p38 phosphorylation
inhibitor SB203580 (gray columns). *Statistically relevant changes (p < 0.05) in comparison to control.
FIGURE 4 | TGF-β1–mediated contraction of ND fibroblast-populated collagen lattices is p38-dependent. ND cells were seeded in neutralized collagen
solution and treated with TGF-β1 or with a combination of TGF-β1 and p38 phosphorylation inhibitor SB203580 for 24, 48, and 72 h. Gels were detached, the gel
contraction was digitally photo-documented (A) and measured as a reduction of gel surface 24 (black columns), 48 (gray columns), and 72 h (white columns) after
detachment (B). *Statistically significant changes (ANOVA, p > 0.05).
TGF-β1 treatment significantly increased the contractility of cells
after 24-h treatment reducing the gel size to 34% of its initial
size compared with reduction of 42% in the control group.
After 48-h incubation with TGF-β1, gel size was reduced to
29% of the initial surface in comparison with control reduced
to 39%. Incubation of cells with TGF-β1 for 72 h decreased the
surface of the gel to 25% of the initial surface in contrast to
the control with observed 37% initial area decrease. Addition
of p38 phosphorylation inhibitor before TGF- β1 stimulation
blocked observed cell contraction. Thus, after 24-h treatment, gel
surface was reduced to 38% of the initial surface area, after 48 h
to 36% and after 72 h reduction was 34% of the initial surface.
These results support the role of p38 activation in contractility
of fibroblasts and their differentiation into myofibroblasts in the
palmar region of DD patients.
DISCUSSION
Phenotypic changes during differentiation of fibroblasts into
myofibroblasts are promoted by cytokines/chemokines and other
immunomodulators (Lupher and Gallatin, 2006). This process is
a persistent, yet localized inflammation that causes deposition
of ECM components. Same processes are driven by TGF-β1
in DD (Krause et al., 2011). TGF-β1 protein family members
transmit signals through type I and type II serine/threonine
kinase receptors that further transduce the signal into the
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cytoplasm through phosphorylation of receptor-regulated Smad
proteins. Activated R-Smads then regulate gene expression, i.e.,
expression of plasminogen activator inhibitor 1 gene (PAI-1),
observed in the presented study as well (Table 2; (Krause et al.,
2011)) and/or mitogen-activated protein (MAP) kinase signaling
pathway genes (Figure 1; Moustakas and Heldin, 2005; Ratkaj
et al., 2012). A number of papers describe the role of TGF-
β1 in increased contractive properties of Dupuytren-derived
cells (Wong and Mudera, 2006; Bisson et al., 2009). It has
a role in induction of genes coding for ECM components as
well, such as for example elastin, myelin basic protein and
thrombospondin-1 (Ratkaj et al., 2012). In the presented study
we analyzed cytokines and chemokines induced by TGF-β1
in primary derived fibroblast from unaffected palmar tissue
of DD patients. Upon treatment, the most prominently over-
expressed inflammatory gene was chemokine 11 (CCL11).
Expression levels of CCL11 diminished upon inhibition of
p38 kinase phosphorylation (Figure 1B). Even though the role
of chemokine CCL11 (eotaxin-1) was already described in
proliferation of lung and bronchial fibroblasts (Rokudai et al.,
2006), angiogenesis, expression of MMP-2, and the synthesis of
type I collagen, its role was not described in cell contraction
and differentiation processes (Huaux et al., 2005; Puxeddu
et al., 2006). Therefore, CCL11 might be involved in the
early phases of fibroblast differentiation when it induces up-
regulation of several fibrogenic factors or chemokines (Tomasek
et al., 2002), where other factors, i.e., TGF-β1 are required
for further progression of this process. Furthermore, a role
for CCL11 may be in triggering migration of progenitor mast
cells toward the inflamed area and their activation during
fibrotic changes (Price et al., 2003). Indeed, increased amount
of mast cells was already observed in DD where they might
actively participate in DD pathogenesis with CCL11 (Schubert
et al., 2006). Additionally, it has been found that fibroblasts
express CCR3 receptor that specifically binds the CCL11 ligand.
Activated CCR3 probably induces fibroblasts proliferation and
differentiation during fibrosis in an autocrine manner (Huaux
et al., 2005). However, we were unable to detect CCR3 gene
transcripts, meaning that it is either not expressed in palmar
fibroblasts or its expression occurs later on during disease
progression (Hogaboam et al., 1998; Huber et al., 2000). Altered
gene expression level in ND cells treated with TGF-β1 was
observed for IL-6 gene as well. IL-6 is cytokine produced by
fibroblasts where it contributes to the development of fibrosis
and inhibition of fibroblasts’ apoptosis (Bunker et al., 2000; Liu
et al., 2007; Genotyping results for IL-6 gene are presented in
Supplementary Material). IL-6 is a profibrogenic cytokine and
its expression was already well-documented in different fibrotic
diseases (Seong et al., 2009). Interestingly, primary fibroblasts
grown from unaffected palmar fascia of DD patients express
the IL-6R gene as well. Therefore, IL-6 trans-signaling promotes
release of IL-6 from fibroblasts and endothelial cells in a positive
autocrine feedback system, which is probably the case in our
model as well.
Alteration in inflammatory genes observed in this study
was accompanied by a number of proteins secreted in the cell
growth media with a known role in ECM remodeling. These
include matrix metalloproteinase 2 (MMP-2), tissue inhibitor of
matrix metalloproteinase 1 (TIMP-1), and plasminogen activator
inhibitor 1 (PAI-1) proteins. Overexpression of PAI-1 and
TIMP-1 was validated on the gene level as well (Figure 3).
Their transcripts levels diminished upon p38 phosphorylation
inhibition. Similar results were reported by Leivonen et al.
(2013) who identified p38 and ERK 1/2 as the key signal
transducers of TGF-ß/Smad 3-induced overexpression of TIMP-
3. They also found an overexpression of TIMP1 and PAI-1
after treatment with TGF-ß, whose influence was attenuated
with p38 inhibitor. Increased amounts of PAI-1 have also been
described in other fibroproliferative diseases as well (Sisson and
Simon, 2007; Wang et al., 2007). Moreover, Tuan et al. (2008)
showed that treatment of keloid fibroblasts with PAI-1 specific
polyclonal antibody or siRNA leads to decreased synthesis and
deposition of the ECM. To our knowledge, the relationship
between TGF-β1 and PAI-1 has not yet been described in DD
tissues and we hypothesize that PAI-1 expression is probably
increased in patients’ palmar tissue as well. Furthermore, its
role may include inhibition of metalloproteinases (MMP). The
MMP expression is indeed usually low in homeostasis (Clark
et al., 2008) but high during extracellular matrix deposition. For
example, it was recently found that MMP-14 silencing inhibits
activation of proMMP-2 in fibroblasts isolated from affected
DD tissues and that silencing of MMP-14 and MMP-2 genes
may inhibit cell-mediated contractions (Wilkinson et al., 2012).
Similarly, we observed elevated levels of TIMP-1 in TGF-β1
treated ND cells as well, which probably play a role in the
inhibition of MMPs (Tuan et al., 2008). The balance between
MMPs and TIMPs is critical for changes in the ECM and
increased amounts of TIMPs have been previously observed in
other fibrotic diseases (Chirco et al., 2006). For example, cords
and nodules in DD have significantly increased levels of TIMP-
1, TIMP-2, and MMP-2 gene expression of in comparison with
control samples (Ulrich et al., 2009). Our results are consistent
with these data as TGF-β1 increased the expression of TIMP-
1 and MMP-2 both at the gene and protein levels which
was visible as increased contractile force in the gel-contraction
assay. This process was again reversed by inhibition of p38
phosphorylation.
In conclusion, our study provides additional evidence on
the p38 MAPK signaling events in primary cells derived from
DD patients’ palmar fascia. In particular, TGF-β1-induced
p38 phosphorylation in ND cells grown from macroscopically
unaffected palmar fascia adjacent to the disease tissue of DD
patients occurs with the activation of cytokine genes CCL-11
and IL-6 and secretion of extracellular matrix regulatory proteins
PAI-1 and TIMP-1. Dual targeting of inflammation and p38
MAPK signaling in DD should be considered as a novel strategy
for advancing the management of DD patients and prevention of
disease recurrence.
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